Mirae Asset Global Investments Co., Ltd. - ARROWHEAD PHARMACEUTICALS IN ownership

ARROWHEAD PHARMACEUTICALS IN's ticker is ARWR and the CUSIP is 04280A100. A total of 288 filers reported holding ARROWHEAD PHARMACEUTICALS IN in Q1 2021. The put-call ratio across all filers is 0.47 and the average weighting 0.3%.

Quarter-by-quarter ownership
Mirae Asset Global Investments Co., Ltd. ownership history of ARROWHEAD PHARMACEUTICALS IN
ValueSharesWeighting
Q3 2023$8,017,202
-18.2%
298,370
+8.6%
0.02%
-14.3%
Q2 2023$9,797,831
+16.7%
274,696
-16.9%
0.02%
+5.0%
Q1 2023$8,398,713
-34.7%
330,658
+4.3%
0.02%
-39.4%
Q4 2022$12,862,833
+53.8%
317,131
+25.3%
0.03%
+43.5%
Q3 2022$8,365,000
+9.9%
253,126
+17.1%
0.02%
+21.1%
Q2 2022$7,613,000
-44.7%
216,205
-27.8%
0.02%
+26.7%
Q1 2022$13,768,000
+17.4%
299,380
+69.2%
0.02%
-40.0%
Q4 2021$11,731,000
+20.8%
176,925
+13.7%
0.02%0.0%
Q3 2021$9,714,000
-6.0%
155,589
+24.6%
0.02%
-13.8%
Q2 2021$10,339,000
+37.2%
124,836
+9.8%
0.03%
+11.5%
Q1 2021$7,537,000
+56.4%
113,659
+81.0%
0.03%
+44.4%
Q4 2020$4,818,000
+102.4%
62,794
+13.6%
0.02%
+50.0%
Q3 2020$2,380,000
+37.9%
55,269
+38.3%
0.01%
+20.0%
Q2 2020$1,726,000
+117.1%
39,974
+44.7%
0.01%
+66.7%
Q1 2020$795,000
-43.5%
27,633
+24.5%
0.01%
-33.3%
Q4 2019$1,408,000
+88.5%
22,190
-16.2%
0.01%
+80.0%
Q3 2019$747,000
+262.6%
26,494
+241.4%
0.01%
+400.0%
Q2 2019$206,0007,7610.00%
Other shareholders
ARROWHEAD PHARMACEUTICALS IN shareholders Q1 2021
NameSharesValueWeighting ↓
Western Financial Corp/CA 820,320$33,272,17921.56%
Aquilo Capital Management, LLC 1,103,515$44,758,56816.81%
M28 Capital Management LP 143,900$5,836,5845.56%
WEALTH EFFECTS LLC 155,620$6,311,9513.60%
Evolutionary Tree Capital Management, LLC 92,095$3,735,3733.59%
Privium Fund Management B.V. 221,015$8,867,1223.36%
JOHNSON & JOHNSON 247,598$10,0432.92%
COMMODORE CAPITAL LP 462,111$18,7432.82%
Avidity Partners Management LP 1,375,000$55,770,0001.21%
Capital Impact Advisors, LLC 26,853$1,089,1581.06%
View complete list of ARROWHEAD PHARMACEUTICALS IN shareholders